Westford, U.S., Sept. 12, 2022 (GLOBE NEWSWIRE) — Growth of Global Hormone Replacement Therapy Market is on the rise as women try to treat symptoms like hot flashes, mood swings and reduced fertility. Although HRT has been around for decades, its recent surge in popularity can be attributed to a variety of factors, including increasing awareness of hormone-related health conditions and the increasing availability of treatments such as testosterone therapy.
HRT can be helpful in treating many conditions related to female hormones, such as hot flashes, menopausal symptoms and low estrogen levels. According to the most recent data from the National Health Interview Survey, 18% of American women over the age of 40 are using HRT. According to the American Society of Reproductive Medicine, the use of HRT in postmenopausal women has increased by 66% since 2001.
There are a variety of drugs currently available in the global hormone replacement therapy market. These include natural hormones such as estradiol and progesterone, synthetic hormones such as Climacteric HRT™ (testosterone), premixed formulations such as Prempro™ (etoposide, etomidate and propranolol), the Igel® transdermal patch and the injectable Depo-Provera™. Some patients choose to self-administer hormones by administering topical creams or gels or by taking oral tablets.
Get a sample copy of this report:
https://skyquestt.com/sample-request/hormone-replacement-therapy-market
The demand for HRT is growing due to the aging population and the increasing prevalence of chronic diseases such as Alzheimer’s and heart disease. The SkyQuest study showed that HRT can reduce the risk of developing these diseases by up to 50%. In addition, HRT has been shown to improve overall sexual function and quality of life in women.
SkyQuest report on the global Hormone Replacement Therapy Market provides insights into the demand and supply gap, current products available in the market, top players and their market share, revenue, production capacity and key catering…
